首页> 外文期刊>American Journal of Physiology >Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy
【24h】

Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy

机译:胎盘生长因子逆转血管和子属MMP-2和MMP-9和MMP-1和MMP-7和胶原蛋白类型和IV中的血管妊娠中的MMP-1和MMP-7增加

获取原文
获取原文并翻译 | 示例
           

摘要

Preeclampsia is a complication of pregnancy manifested as maternal hypertension (HTN) and fetal intrauterine growth restriction, with unclear mechanisms. Placental ischemia increases antiangiogenic soluble fms-like tyrosine kinase-1 (sFlt-1) relative to angiogenic placental growth factor (P1GF); however, the molecular targets are unclear. To test the hypothesis that placental ischemia-induced changes in sFlt-1 and P1GF target vascular and uteroplacental matrix metalloproteinases (MMPs), we tested whether raising the sFlt-1-to-PlGF ratio by infusing sFlt-1 (10μg·kg~(-1)day~(-1)) in pregnant (Preg) rats increases blood pressure (BP) and alters MMPs and whether correcting sFlt-1/PlGF by infusing P1GF (20 μg·kg~(-1). day~(-1)) in Preg rats with reduced uterine perfusion pressure (RUPP) improves BP and reverses the changes in MMPs. On gestational day 19, BP was higher and the litter size and uterine, placenta, and pup weight were less in Preg + sFlt-1 and RUPP than Preg rats and restored in RUPP + P1GF versus RUPP rats. Gelatin and casein zymography and Western blots revealed decreases in MMP-2 and MMP-9 and increases in MMP-1 and MMP-7 in the aorta, uterine artery, uterus, and placenta of Preg + sFlt-1 and RUPP versus Preg rats, which were reversed in RUPP + P1GF versus RUPP rats. Collagen types I and IV were more abundant in Preg + sFlt-1 and RUPP versus Preg rats and were reversed in RUPP + P1GF versus RUPP rats. Thus, P1GF reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1, MMP-7, and collagen types I and IV induced by placental ischemia and sFlt-1 in HTN in pregnancy. Angiogenic factors and MMP modulators could rectify changes in MMPs and collagen, restore vascular and uteroplacental remodeling, and improve HTN and intrauterine growth restriction in preeclampsia.
机译:预口度是妊娠的并发症表现为母体高血压(HTN)和胎儿宫内生长限制,机制不明确。胎盘缺血相对于血管生成胎盘生长因子(P1GF)增加抗血管生成可溶性FMS样酪氨酸激酶-1(SFLT-1);然而,分子靶标尚不清楚。为了测试胎盘性缺血诱导的SFLT-1和P1GF靶血管和子属组织基质金属蛋白酶(MMP)的假设,我们测试了通过输注SFLT-1提高SFLT-1-PLGF比(10μg·kg〜(妊娠(PREG)大鼠中的〜(-1))增加血压(BP)和改变MMP,并通过输注P1GF来校正SFLT-1 / PLGF(20μg·kg〜(-1)。日〜( -1))在具有降低的子宫灌注压力(RUPP)的PREG大鼠中改善了BP并反转了MMP的变化。在妊娠第19天,BP较高,PREG + SFLT-1和RUPP的垃圾尺寸和子宫,胎盘和幼崽重量比PREG大鼠较低,并在Rupp + P1GF与Rupp大鼠中恢复。明胶和酪蛋白谱和蛋白质印迹显示在MMP-2和MMP-9中的降低,并且在AORTA,子宫动脉,子宫和PREG + SFLT-1和RUPP与PREG大鼠的胎盘中增加MMP-1和MMP-7,在Rupp + P1GF与Rupp大鼠中逆转。 PREG + SFLT-1和RUPP与PREG大鼠的胶原蛋白类型I和IV更丰富,并在Rupp + P1GF与Rupp大鼠中逆转。因此,P1GF反转减少血管和子宫内膜MMP-2和MMP-9和MMP-1,MMP-7和妊娠中HTN中HTN中的SFLT-1诱导的MMP-1,MMP-7和胶原蛋白类型I和IV的增加。血管生成因子和MMP调节剂可以整流MMP和胶原蛋白的变化,恢复血管和子属改造,并改善预坦克西亚的HTN和宫内生长限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号